Draft:Rory Murphy

• Comment: Fully fails WP:PROF and WP:BIO. The tone is nothing we'd want in an article. We are a tertiary source mostly concerned with reporting what secondary sources say about the subject; this however just sounds like his CV in prose form. Sulfurboy (talk) 05:54, 31 July 2026 (UTC)

---

Dr Rory Murphy is a board-certified neurosurgeon and an associate professor in the Department of Neurosurgery at Barrow Neurological Institute. Dr. Rory Murphy's clinical practice focuses on the surgical treatment of complex cranial and spinal pathologies, including tumors and spinal cord compression. He is a member of the American Association of Neurological Surgeons (AANS), AO Spine, the Congress of Neurological Surgeons (CNS), and the Cervical Spine Research Society Education Committee.

Murphy earned his medical degree from University College Cork in Ireland. He completed his neurosurgery residency at Washington University in St. Louis, and a fellowship at the University of California-San Francisco.

Murphy is active in translational research. He is an investigator on Elon Musk's Neuralink Precise & Convoy studies and an investigator for the Department of Defense Cervical Spinal Cord Injury Hypothermia Trial. His research has been published in Nature, Journal of Neurosurgery, Neurosurgery, and Spine.

Murphy has co-founded and advised several medical-device companies focused on neurotechnology, spinal surgery, and physician safety. He is a co-founder of Intelligent Implants, which is developing wireless, battery-free spinal implants designed to stimulate and monitor bone growth following spinal fusion. In 2021, the company announced €7.5 million ($8.7 million) in financing to support development of its implantable technology. Murphy is also a co-founder and medical adviser to Fortega Medical, a member of NeuroBell’s clinical advisory board, and a scientific adviser to Neuvotion. NeuroBell develops portable electroencephalography systems incorporating automated neonatal seizure detection, while Neuvotion develops artificial-intelligence-guided neurostimulation and brain–body interface technologies.

In 2016, while working as a neurosurgeon at the Washington University School of Medicine, Murphy collaborated with materials scientist John A. Rogers and a multidisciplinary engineering team to develop a bioresorbable intracranial sensor for monitoring patients with traumatic brain injuries. The device was designed to measure intracranial pressure for several days before dissolving and being absorbed by the body, potentially eliminating the need for an additional procedure to remove the sensor. In preclinical studies conducted by Murphy, the device demonstrated accuracy comparable to conventional pressure monitors and did not produce a detectable inflammatory or immune response. The researchers subsequently planned further large-animal safety studies as a step toward clinical testing in humans.

Murphy was featured in Wired magazine in connection with Coherence Neuro, a San Francisco-based startup developing a brain-computer interface designed to detect and treat brain tumors using targeted electrical stimulation. The article reports that Murphy, a clinical trial investigator in Neuralink's programs, is slated to be involved in Coherence Neuro's future human trials, which aim to transform glioblastoma from a terminal diagnosis into a continuously monitored and managed condition.

Murphy is a trustee of Myelopathy.org, an international, patient-focused charity that promotes collaboration among people affected by degenerative cervical myelopathy, clinicians, and researchers, with the aim of raising awareness and improving patient outcomes. Degenerative cervical myelopathy is considered the most common cause of spinal cord dysfunction in adults. Murphy also serves on the advisory board of the Barrow Neurological Institute at Phoenix Children’s Hospital.

He has been named a PHOENIX Magazine Top Doctor four consecutive years: 2023, 2024, 2025, and 2026.